AI
CLB icon

Analytic Investors’s Core Laboratories CLB Stock Holding History

Analytic Investors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,528
Closed -$2.54M – 605
2016
Q2 		$2.54M Buy
+20,528
New +$2.48M 0.03% 250

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

Analytic Investors's CLB Position: Q3 2016 in Review

Analytic Investors sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 20,528 shares — an estimated $2.54M sold.

Analytic Investors first reported a position in CLB in Q2 2016 and held it in 1 quarter. The position peaked at $2.54M in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Analytic Investors reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 20,528 Core Laboratories shares in Q3 2016, an estimated $2.54M.
  • Analytic Investors first reported a position in Core Laboratories in Q2 2016 and held it in 1 quarter.
  • Analytic Investors's Core Laboratories position peaked at $2.54M in Q2 2016.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.